COMPANY:

miR Scientific

"miR Scientific...announces today that it has received Accreditation from the College of American Pathologists (CAP) for its Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in North Brunswick, New Jersey. CAP accreditation is only awarded to laboratories that meet the stringent standards for laboratory operations and management."

"miR Scientific, LLC announces the miR Sentinel™ Prostate Cancer Test is now commercially available in the United States, Puerto Rico and select international markets. miR Sentinel™ is a novel, urine-based, molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm. The miR Sentinel™ Test assesses the risk of aggressive prostate cancer and is intended to aid in the clinical management of men >45 years of age at risk for prostate cancer." "

"miR Scientific...and Leonie Hill Capital...announced today the signing of a collaboration agreement to partner in the commercial launch of the award-winning miR Sentinel™ Prostate Cancer Test in Singapore and Southeast Asia."

"miR Scientific announced at the Puerto Rico Urologists Convention that it will open a registry of patients who wish to receive the new miR Sentinel™ Prostate Cancer Test, which the company expects will be commercially available by the end of the year."